These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

202 related items for PubMed ID: 19929725

  • 1. Beyond Guam: cyanobacteria, BMAA and sporadic amyotrophic lateral sclerosis.
    Bradley WG, Cox PA.
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():5-6. PubMed ID: 19929725
    [No Abstract] [Full Text] [Related]

  • 2. Proceedings from the symposium "Beyond Guam: New aspects of the Cyanobacteria/BMAA Hypothesis", 4 November 2008, UK.
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():5-126. PubMed ID: 20213893
    [No Abstract] [Full Text] [Related]

  • 3. Beyond Guam: the cyanobacteria/BMAA hypothesis of the cause of ALS and other neurodegenerative diseases.
    Bradley WG, Mash DC.
    Amyotroph Lateral Scler; 2009; 10 Suppl 2():7-20. PubMed ID: 19929726
    [Abstract] [Full Text] [Related]

  • 4. Commentary on: Return of the cycad hypothesis--does the amyotrophic lateral sclerosis/Parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?
    Cox PA, Banack S, Murch S, Sacks O.
    Neuropathol Appl Neurobiol; 2006 Dec; 32(6):679-82. PubMed ID: 17083482
    [No Abstract] [Full Text] [Related]

  • 5. Possible therapy for ALS based on the cyanobacteria/BMAA hypothesis.
    Bradley WG.
    Amyotroph Lateral Scler; 2009 Dec; 10 Suppl 2():118-23. PubMed ID: 19929743
    [Abstract] [Full Text] [Related]

  • 6. Aerosolization of cyanobacteria as a risk factor for amyotrophic lateral sclerosis.
    Stommel EW, Field NC, Caller TA.
    Med Hypotheses; 2013 Feb; 80(2):142-5. PubMed ID: 23246360
    [Abstract] [Full Text] [Related]

  • 7. Cyanobacteria and BMAA exposure from desert dust: a possible link to sporadic ALS among Gulf War veterans.
    Cox PA, Richer R, Metcalf JS, Banack SA, Codd GA, Bradley WG.
    Amyotroph Lateral Scler; 2009 Feb; 10 Suppl 2():109-17. PubMed ID: 19929742
    [Abstract] [Full Text] [Related]

  • 8. Return of the cycad hypothesis - does the amyotrophic lateral sclerosis/parkinsonism dementia complex (ALS/PDC) of Guam have new implications for global health?
    Ince PG, Codd GA.
    Neuropathol Appl Neurobiol; 2005 Aug; 31(4):345-53. PubMed ID: 16008818
    [Abstract] [Full Text] [Related]

  • 9. Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam.
    Murch SJ, Cox PA, Banack SA, Steele JC, Sacks OW.
    Acta Neurol Scand; 2004 Oct; 110(4):267-9. PubMed ID: 15355492
    [Abstract] [Full Text] [Related]

  • 10. Toxin types, toxicokinetics and toxicodynamics.
    Humpage A.
    Adv Exp Med Biol; 2008 Oct; 619():383-415. PubMed ID: 18461776
    [No Abstract] [Full Text] [Related]

  • 11. The ALS/PDC syndrome of Guam and the cycad hypothesis.
    Cruz-Aguado R, Shaw CA.
    Neurology; 2009 Feb 03; 72(5):474, 476; author reply 475-6. PubMed ID: 19195085
    [No Abstract] [Full Text] [Related]

  • 12. Detection of the neurotoxin BMAA within cyanobacteria isolated from freshwater in China.
    Li A, Tian Z, Li J, Yu R, Banack SA, Wang Z.
    Toxicon; 2010 May 03; 55(5):947-53. PubMed ID: 19822166
    [Abstract] [Full Text] [Related]

  • 13. Cyanobacteria biomagnification and amyotrophic lateral sclerosis.
    Stipa G, Manganelli M, Lolli F.
    Med Hypotheses; 2013 Aug 03; 81(2):356-7. PubMed ID: 23673195
    [No Abstract] [Full Text] [Related]

  • 14. The ALS/PDC syndrome of Guam and the cycad hypothesis.
    Bradley WG, Banack SA, Cox PA.
    Neurology; 2009 Feb 03; 72(5):473-4, 476; author reply 475-6. PubMed ID: 19195084
    [No Abstract] [Full Text] [Related]

  • 15. Multiple neurotoxic items in the Chamorro diet link BMAA with ALS/PDC.
    Banack SA, Murch SJ.
    Amyotroph Lateral Scler; 2009 Feb 03; 10 Suppl 2():34-40. PubMed ID: 19929729
    [Abstract] [Full Text] [Related]

  • 16. Analysis of BMAA enantiomers in cycads, cyanobacteria, and mammals: in vivo formation and toxicity of D-BMAA.
    Metcalf JS, Lobner D, Banack SA, Cox GA, Nunn PB, Wyatt PB, Cox PA.
    Amino Acids; 2017 Aug 03; 49(8):1427-1439. PubMed ID: 28620737
    [Abstract] [Full Text] [Related]

  • 17. The discovery of BMAA, and examples of biomagnification and protein incorporation involving other non-protein amino acids.
    Bell EA.
    Amyotroph Lateral Scler; 2009 Aug 03; 10 Suppl 2():21-5. PubMed ID: 19929727
    [Abstract] [Full Text] [Related]

  • 18. Neurodegenerative disease. Guam's deadly stalker: on the loose worldwide?
    Miller G.
    Science; 2006 Jul 28; 313(5786):428-31. PubMed ID: 16873621
    [No Abstract] [Full Text] [Related]

  • 19. Human exposure to cyanobacteria and BMAA.
    Brand LE.
    Amyotroph Lateral Scler; 2009 Jul 28; 10 Suppl 2():85-95. PubMed ID: 19929739
    [Abstract] [Full Text] [Related]

  • 20. BMAA--an unusual cyanobacterial neurotoxin.
    Vyas KJ, Weiss JH.
    Amyotroph Lateral Scler; 2009 Jul 28; 10 Suppl 2():50-5. PubMed ID: 19929732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.